Abstract
In modern realities, medicine is an object of close attention, both from regulatory organizations and from social media. In such conditions of constant monitoring and pressure, clinical trials of newly developed immunobiological drugs (IBD) require effective legal support for all stages of the trials, as well as proper legal protection of volunteers in clinical trials of the effectiveness and safety of IBD, taking into account all possible risks. In the presented review, the Russian and foreign experience of legal support of this sphere of public relations is studied using the example of a vaccine against coronavirus infection, as well as proposals for its improvement.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
